Perspectives

Dr. Weichang Zhou, CTO and executive vice president of WuXi Biologics, recently had an article published on industry media website Bioprocess International. He introduced how to leverage advancing technologies to enable collaboration and innovation. Here we picked a paragraph to summarize his opinions. Please click the link to read the full article.

“Recent global events have demonstrated a growing demand for biologics to be made rapidly, cost-effectively, and in high volumes. There has been an urgent need to develop highly flexible and cost-effective next-generation biomanufacturing solutions that provide high yields of therapeutic proteins. Novel technology platforms such as single-use bioreactors and continuous bioprocessing technologies have contributed greatly to improvements in product quality and productivity while reducing cost of goods.”